Tameryn conducted her Ph.D. on the development of metal-based antimalarials at the University of Cape Town, South Africa and graduated in 2014. She worked as a Postdoctoral Research Fellow at the University of Cape Town until 2017 and also conducted postdoctoral research in Bioorganometallic chemistry at Lund University between 2017 and 2018. In 2020, she moved to the UK to take up the position of Teaching and Research Fellow at the University of Leeds until she moved to the University of East Anglia in August of 2021. Tameryn is a synthetic chemist with expertise in the design, synthesis and characterisation of organic and metal-based compounds as potential biological agents. Tameryn’s research interest involves working towards the development of metallodrugs to combat cancer as well as infectious diseases, including malaria. 

Dr Stringer's main research interest focuses on the development of metal complexes for therapeutic purposes but is also interested in identifying the biological targets of small molecules and metallodrugs using a range of in vitro methodologies. 

Tameryn has extensive experience in the design, synthesis and application of organometallics for an array of diseases, including cancer. Her main research interest focuses on the development of metal complexes for therapeutic purposes but is also interested in identifying the biological targets of small molecules and metallodrugs using a range of in vitro methodologies. As a new member of staff at UEA, she aims to advance her research towards the development of protein-targeting metallodrugs and chemical probes in order to understand mechanisms of action. Tameryn, alongside Dr Rianne Lord and her group, works towards the development of novel metal-based anticancer agents.

Lord Research Group